Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polio vaccine (Melem Secrets) is a trivalent vaccine indicated for the prevention of poliomyelitis, targeting poliovirus types 1, 2, and 3. It is available in two primary formulations: an Inactivated Poliovirus Vaccine (IPV) administered via intramuscular or subcutaneous injection, and an Oral Poliovirus Vaccine (OPV) administered orally. The vaccine works by inducing active immunity, specifically the production of neutralizing antibodies that prevent the virus from infecting the central nervous system and causing paralytic disease. Melem Secrets (associated with Shenzhen Mellow Hope Pharm Industrial Co., Ltd.) acts as a distributor and exporter for these commercially approved vaccine products, facilitating their global availability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polio vaccine (Melem Secrets).